- Home
- STRO vs DSM Comparison
STRO vs DSM Comparison
Compare STRO & DSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STRO | DSM |
|---|---|---|
| Founded | 2003 | 1989 |
| Country | United States | United States |
| Employees | 131 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 338.9M | 306.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | STRO | DSM |
|---|---|---|
| Price | $24.32 | $5.80 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $26.38 | N/A |
| AVG Volume (30 Days) | ★ 167.1K | 88.0K |
| Earning Date | 03-23-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.97% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.45 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.52 | $5.28 |
| 52 Week High | $27.96 | $6.30 |
Technical Indicators
Market Signals| Indicator | STRO | DSM |
|---|---|---|
| Relative Strength Index (RSI) | 63.75 | 24.36 |
| Support Level | $0.76 | $5.68 |
| Resistance Level | $27.96 | $6.24 |
| Average True Range (ATR) | 2.27 | 0.06 |
| MACD | -0.13 | -0.02 |
| Stochastic Oscillator | 62.81 | 7.35 |
Price Performance
Historical ComparisonAbout STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.